Literature DB >> 23843038

Role of bacterial infections in pancreatic cancer.

Dominique S Michaud1.   

Abstract

Established risk factors for pancreatic cancer, including tobacco smoking, chronic pancreatitis, obesity and type 2 diabetes, collectively account for less than half of all pancreatic cancer cases. Inflammation plays a key role in pancreatic carcinogenesis, but it is unclear what causes local inflammation, other than pancreatitis. Epidemiological data suggest that Helicobacter pylori may be a risk factor for pancreatic cancer, and more recently, data suggest that periodontal disease, and Porphyromonas gingivalis, a pathogen for periodontal disease, may also play a role in pancreatic carcinogenesis. Individuals with periodontal disease have elevated markers of systemic inflammation, and oral bacteria can disseminate into the blood, stomach, heart and even reach the brain. These infections may contribute to the progression of pancreatic cancer by acting jointly with other pancreatic cancer risk factors that impact the inflammation and immune response, such as smoking and obesity, and the ABO genetic variant, recently linked to pancreatic cancer through genome-wide association studies. The complex interplay between bacteria, host immune response and environmental factors has been examined closely in relation to gastric cancer, but new research suggests bacteria may be playing a role in other gastrointestinal cancers. This review will summarize the literature on epidemiological studies examining infections that have been linked to pancreatic cancer and propose mechanistic pathways that may tie infections to pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23843038      PMCID: PMC3786384          DOI: 10.1093/carcin/bgt249

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  70 in total

Review 1.  Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.

Authors:  Dong Tang; Daorong Wang; Zhongxu Yuan; Xiaofeng Xue; Ye Zhang; Yong An; Jianmin Chen; Min Tu; Zipeng Lu; Jishu Wei; Kuirong Jiang; Yi Miao
Journal:  Int J Cancer       Date:  2012-10-05       Impact factor: 7.396

2.  Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans.

Authors:  Atsuo Ochi; Christopher S Graffeo; Constantinos P Zambirinis; Adeel Rehman; Michael Hackman; Nina Fallon; Rocky M Barilla; Justin R Henning; Mohsin Jamal; Raghavendra Rao; Stephanie Greco; Michael Deutsch; Marco V Medina-Zea; Usama Bin Saeed; Melvin O Ego-Osuala; Cristina Hajdu; George Miller
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

Review 3.  The pancreas cancer microenvironment.

Authors:  Christine Feig; Aarthi Gopinathan; Albrecht Neesse; Derek S Chan; Natalie Cook; David A Tuveson
Journal:  Clin Cancer Res       Date:  2012-08-15       Impact factor: 12.531

4.  ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.

Authors:  De-Shen Wang; Dong-Liang Chen; Chao Ren; Zhi-Qiang Wang; Miao-Zhen Qiu; Hui-Yan Luo; Dong-Sheng Zhang; Feng-Hua Wang; Yu-Hong Li; Rui-Hua Xu
Journal:  Int J Cancer       Date:  2011-11-30       Impact factor: 7.396

Review 5.  The impact of obesity on the immune response to infection.

Authors:  J Justin Milner; Melinda A Beck
Journal:  Proc Nutr Soc       Date:  2012-03-14       Impact factor: 6.297

6.  Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4).

Authors:  E J Duell; E Lucenteforte; S H Olson; P M Bracci; D Li; H A Risch; D T Silverman; B T Ji; S Gallinger; E A Holly; E H Fontham; P Maisonneuve; H B Bueno-de-Mesquita; P Ghadirian; R C Kurtz; E Ludwig; H Yu; A B Lowenfels; D Seminara; G M Petersen; C La Vecchia; P Boffetta
Journal:  Ann Oncol       Date:  2012-07-05       Impact factor: 32.976

Review 7.  microRNA involvement in human cancer.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Carcinogenesis       Date:  2012-04-03       Impact factor: 4.944

8.  Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data.

Authors:  Peng Wei; Hongwei Tang; Donghui Li
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

9.  MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.

Authors:  Atsuo Ochi; Andrew H Nguyen; Andrea S Bedrosian; Harry M Mushlin; Saman Zarbakhsh; Rocky Barilla; Constantinos P Zambirinis; Nina C Fallon; Adeel Rehman; Yuliya Pylayeva-Gupta; Sana Badar; Cristina H Hajdu; Alan B Frey; Dafna Bar-Sagi; George Miller
Journal:  J Exp Med       Date:  2012-08-20       Impact factor: 14.307

Review 10.  MicroRNAs and toll-like receptor/interleukin-1 receptor signaling.

Authors:  Anthony Virtue; Hong Wang; Xiao-feng Yang
Journal:  J Hematol Oncol       Date:  2012-10-18       Impact factor: 17.388

View more
  60 in total

1.  Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.

Authors:  Mingfeng Zhang; Soren Lykke-Andersen; Bin Zhu; Wenming Xiao; Jason W Hoskins; Xijun Zhang; Lauren M Rost; Irene Collins; Martijn van de Bunt; Jinping Jia; Hemang Parikh; Tongwu Zhang; Lei Song; Ashley Jermusyk; Charles C Chung; Bin Zhu; Weiyin Zhou; Gail L Matters; Robert C Kurtz; Meredith Yeager; Torben Heick Jensen; Kevin M Brown; Halit Ongen; William R Bamlet; Bradley A Murray; Mark I McCarthy; Stephen J Chanock; Nilanjan Chatterjee; Brian M Wolpin; Jill P Smith; Sara H Olson; Gloria M Petersen; Jianxin Shi; Laufey Amundadottir
Journal:  Gut       Date:  2017-06-20       Impact factor: 23.059

2.  Gut immunoglobulin alpha anti-glycan binding profiles as a research tool for local disease detection.

Authors:  Joseph J Otto; Crystal L Daniels; Lindsay N Schambeau; Brittany N Williams; Jana M Rocker; Lewis K Pannell
Journal:  Glycoconj J       Date:  2018-06-09       Impact factor: 2.916

Review 3.  Periodontal Disease, Tooth Loss, and Cancer Risk.

Authors:  Dominique S Michaud; Zhuxuan Fu; Jian Shi; Mei Chung
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

Review 4.  Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association.

Authors:  K R Atanasova; O Yilmaz
Journal:  Mol Oral Microbiol       Date:  2014-02-08       Impact factor: 3.563

5.  Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.

Authors:  Yuko Yamaoka; Yutaka Suehiro; Shinichi Hashimoto; Tomomi Hoshida; Michiyo Fujimoto; Michiya Watanabe; Daiki Imanaga; Kouhei Sakai; Toshihiko Matsumoto; Mitsuaki Nishioka; Taro Takami; Nobuaki Suzuki; Shoichi Hazama; Hiroaki Nagano; Isao Sakaida; Takahiro Yamasaki
Journal:  J Gastroenterol       Date:  2017-08-19       Impact factor: 7.527

6.  Oral Pathobiont Activates Anti-Apoptotic Pathway, Promoting both Immune Suppression and Oncogenic Cell Proliferation.

Authors:  Pachiappan Arjunan; Mohamed M Meghil; Wenhu Pi; Jinxian Xu; Liwei Lang; Ahmed El-Awady; William Sullivan; Mythilypriya Rajendran; Mariana Sousa Rabelo; Tong Wang; Omnia K Tawfik; Govindarajan Kunde-Ramamoorthy; Nagendra Singh; Thangaraju Muthusamy; Cristiano Susin; Yong Teng; Roger M Arce; Christopher W Cutler
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

7.  Periodontal disease, tooth loss and colorectal cancer risk: Results from the Nurses' Health Study.

Authors:  Fatemeh Momen-Heravi; Ana Babic; Shelley S Tworoger; Libin Zhang; Kana Wu; Stephanie A Smith-Warner; Shuji Ogino; Andrew T Chan; Jeffrey Meyerhardt; Edward Giovannucci; Charles Fuchs; Eunyoung Cho; Dominique S Michaud; Meir J Stampfer; Yau-Hua Yu; David Kim; Xuehong Zhang
Journal:  Int J Cancer       Date:  2016-11-23       Impact factor: 7.396

Review 8.  Oral bacteria in pancreatic cancer: mutagenesis of the p53 tumour suppressor gene.

Authors:  Mesut Öğrendik
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

10.  The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.

Authors:  Ana S Leal; Michael B Sporn; Patricia A Pioli; Karen T Liby
Journal:  Carcinogenesis       Date:  2016-09-22       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.